Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELAY: Natpara Dose-Finding in Hypoparathyroidism
NCT01268098Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2011
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of parathyroid hormone 1-84 in hypoparathyroidism, sponsored by Takeda. Started Feb 2011; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT01268098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01268098.